Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Sales of Property, Plant and Equipment (2025)

Updated

Amneal Pharmaceuticals (AMRX) recorded Sales of Property, Plant and Equipment of $715,000 in Q4 2025.

Analysis

Amneal Pharmaceuticals (AMRX) Sales of Property, Plant and Equipment (2025) Analysis & Trends

For FY2025, Amneal Pharmaceuticals reported Sales of Property, Plant and Equipment of $2.09 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -4.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 1.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 715,000.00
Jun 30, 2025 855,000.00
Mar 31, 2025 524,000.00
API Access

Amneal Pharmaceuticals Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=AMRX&period=max&api_key=YOUR_API_KEY